If you do get side effects, theyre likely to be mild to moderate, and typically stop happening as your body gets used to the medication
As a GLP-1, GIP, and glucagon receptor agonist being evaluated for obesity and type 2 diabetes, retatrutide shares some skin-related adverse effects with other subcutaneous incretin therapies, whilst its full dermatological profile remains under investigation
If you want straightforward primary care with optional GLP-1 access and dont mind slower medication turnaround, Amazon One Medical can be a convenient fit
The main difference is their regulatory approval: Wegovy and Zepbound are different drugs that both aim to help with weight loss
Endogenous antioxidant activities in relation to concurrent vitamins A, C, and E intake in dementia
Journal reference: Sawicka-Gutaj N, Gruszczyski D, Nijakowski K, et al